183 related articles for article (PubMed ID: 37187951)
1. Optimal Protocol and Clinical Usefulness of
Chun IK
Nucl Med Mol Imaging; 2023 Jun; 57(3):145-154. PubMed ID: 37187951
[TBL] [Abstract][Full Text] [Related]
2. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
[TBL] [Abstract][Full Text] [Related]
3. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
[TBL] [Abstract][Full Text] [Related]
4. A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
Iwabuchi Y; Kameyama M; Matsusaka Y; Narimatsu H; Hashimoto M; Seki M; Ito D; Tabuchi H; Yamada Y; Jinzaki M
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1833-1841. PubMed ID: 33392714
[TBL] [Abstract][Full Text] [Related]
5.
Catalan M; Dore F; Polverino P; Bertolotti C; Sartori A; Antonutti L; Cucca A; Furlanis G; Capitanio S; Manganotti P
Mov Disord Clin Pract; 2021 Jul; 8(5):717-724. PubMed ID: 34295947
[TBL] [Abstract][Full Text] [Related]
6. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
7. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
[TBL] [Abstract][Full Text] [Related]
8.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease.
Frantellizzi V; Lavelli V; Ferrari C; Sardaro A; Farcomeni A; Pacilio M; Borrazzo C; Pani R; Rubini G; Vincentis G
Curr Radiopharm; 2021; 14(1):64-69. PubMed ID: 32720610
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
Brandl SJ; Braune S
Clin Auton Res; 2019 Dec; 29(6):567-574. PubMed ID: 29869732
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
[TBL] [Abstract][Full Text] [Related]
14. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
15. Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice.
Skowronek C; Zange L; Lipp A
Front Neurol; 2019; 10():152. PubMed ID: 30863360
[No Abstract] [Full Text] [Related]
16. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Miyamoto T; Miyamoto M; Suzuki K; Nishibayashi M; Iwanami M; Hirata K
Sleep; 2008 May; 31(5):717-23. PubMed ID: 18517041
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of cardiac
Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
19. Potential diagnostic value of
Abbasi M; Ghalandari N; Farzanefar S; Aghamollaii V; Ahmadi M; Ganji M; Afarideh M; Loloee S; Naseri M; Tafakhori A
Clin Neurol Neurosurg; 2017 Dec; 163():163-166. PubMed ID: 29112909
[TBL] [Abstract][Full Text] [Related]
20. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
